Last reviewed · How we verify
NCT06075290: NJFU
the Difference of Follow-up Methods of Neonatal Jaundice
trial testing internet plus model in Neonatal Jaundice in 1,000 participants. Status unknown.
10 October 2024
Quick facts
| Lead sponsor | Guizhou Provincial People's Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 10 October 2023 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 May 2025 |
| Sites | 3 locations across China |
Drugs / interventions tested
- internet plus model
- control
Conditions studied
- Neonatal Jaundice — all drugs for Neonatal Jaundice →
Sponsor
Guizhou Provincial People's Hospital
Who can join
Adults 0 Days to 16 Weeks, any sex, with Neonatal Jaundice. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to compare the effectiveness and efficiency for precaution of severe hyperbilirubinemia in neonate by different follow-up methods of neonatal jaundice. There are two kinds of follow-up methods in the investigators clinical practice. The one is internet plus follow-up model, the other is conventional clinic follow-up method. Parents of the participant neonates can choose one by themselves. After parents of the participant signed informed consent, the investigators recorded several information including severe hyperbilirubinemia, length of phototherapy, follow-up times, et al. Then the investigators analysed these data in order to know what kind of follow-up method is better to prevent severe hyperbilirubinemia and more easy to be accepted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06075290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Jaundice
Currently open trials in the same condition.
- NCT06963450 — NeoSCB App for Screening Jaundice in Newborns · recruiting
- NCT06399146 — Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana · NA · recruiting
- NCT05521607 — Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago) · NA · recruiting
Other Guizhou Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07446686 — Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-R · EARLY_PHASE1 · not yet recruiting
- NCT05980520 — Study on the Treatment of Taurine in Children With Autism · NA · completed
- NCT05950087 — Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical C · recruiting
- NCT05309174 — The Study of Bilateral Upper Laryngeal Nerve Block for Supporting the Removal of Vocal Cord Polyps Under Laryngoscopy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06075290 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guizhou Provincial People's Hospital
- Last refreshed: 2 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06075290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing